Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.
|
|
Volume 2 (2005), Issue 6 (June)
- A novel nonsteroidal antifibrotic oligo decoy containing the TGF-beta element found in the COL1A1 gene which regulates murine schistosomiasis liver fibrosis.
J Cell Physiol, 204(2): 370-4. [Abstract] [Full-text]
- Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis.
J Autoimmun, 24(4): 347-52. [Abstract] [Full-text]
- The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
Am J Gastroenterol, 100(6): 1311-6. [Abstract] [Full-text]
- Impact of prior portosystemic shunt procedures on outcome of liver transplantation.
Surgery, 137(6): 620-5. [Abstract] [Full-text]
- False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent.
Clin Chim Acta, 356(1): 102-9. [Abstract] [Full-text]
- Biodistribution and hepatic uptake of triplex-forming oligonucleotides against type alpha1(I) collagen gene promoter in normal and fibrotic rats.
Mol Pharm, 2(3): 206-17. [Abstract] [Full-text]
- Natural history of hepatitis C virus-related liver fibrosis after renal transplantation.
Am J Transplant, 5(7): 1704-12. [Abstract] [Full-text]
- Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
Gut, 54(7): 1003-8. [Abstract] [Full-text]
- Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.
Gut, 54(7): 987-93. [Abstract] [Full-text]
- Expression of apolipoprotein AI mRNA in peripheral white blood cells of patients with alcoholic liver disease.
Biochim Biophys Acta, 1740(3): 350-6. [Abstract] [Full-text]
- Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
Transpl Int, 18(7): 879-83. [Abstract] [Full-text]
- Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center.
Transpl Int, 18(7): 794-9. [Abstract] [Full-text]
- Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients.
Aliment Pharmacol Ther, 21(12): 1459-65. [Abstract] [Full-text]
- Gender and liver fibrosis in chronic hepatitis: the role of iron status.
Aliment Pharmacol Ther, 21(12): 1445-51. [Abstract] [Full-text]
- Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation.
Aliment Pharmacol Ther, 21(12): 1435-43. [Abstract] [Full-text]
- Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue.
Ann N Y Acad Sci, 1041: 185-9. [Abstract] [Full-text]
- Brain natriuretic peptide and severity of disease in non-alcoholic cirrhotic patients.
J Gastroenterol Hepatol, 20(7): 1115-20. [Abstract] [Full-text]
- Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability.
J Gastroenterol Hepatol, 20(7): 1109-14. [Abstract] [Full-text]
- Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
J Gastroenterol Hepatol, 20(7): 1102-8. [Abstract] [Full-text]
- Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
J Gastroenterol Hepatol, 20(7): 1075-81. [Abstract] [Full-text]
- Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
Clin Pharmacol Ther, 77(6): 529-41. [Abstract] [Full-text]
- Peginterferon and ribavirin in patients with HCV cirrhosis after liver transplantation.
Transplant Proc, 37(5): 2207-8. [Abstract] [Full-text]
- Orthotopic liver transplantation with vena cava preservation in cirrhotic patients: is systematic temporary portacaval anastomosis a justified procedure?
Transplant Proc, 37(5): 2159-62. [Abstract] [Full-text]
- Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.
Lab Invest, 85(7): 908-20. [Abstract] [Full-text]
- Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis.
Mod Pathol, 18(7): 941-50. [Abstract] [Full-text]
- Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.
Hepatology, 42(1): 27-34. [Abstract] [Full-text]
- Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.
Hepatology, 42(1): 53-62. [Abstract] [Full-text]
- Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
Hepatology, 42(1): 63-71. [Abstract] [Full-text]
- Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
Histopathology, 47(1): 57-66. [Abstract] [Full-text]
- Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.
J Gene Med, 7(7): 965-76. [Abstract] [Full-text]
- Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease.
Am J Gastroenterol, 100(7): 1523-8. [Abstract] [Full-text]
- Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy.
Am J Gastroenterol, 100(7): 1509-15. [Abstract] [Full-text]
- Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.
J Magn Reson Imaging, 22(1): 80-5. [Abstract] [Full-text]
© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.
|
|